172 related articles for article (PubMed ID: 16913569)
1. CD83: a regulatory molecule of the immune system with great potential for therapeutic application.
Fujimoto Y; Tedder TF
J Med Dent Sci; 2006 Jun; 53(2):85-91. PubMed ID: 16913569
[TBL] [Abstract][Full Text] [Related]
2. Transgenic expression of a CD83-immunoglobulin fusion protein impairs the development of immune-competent CD4-positive T cells.
Lüthje K; Cramer SO; Ehrlich S; Veit A; Steeg C; Fleischer B; Bonin Av; Breloer M
Eur J Immunol; 2006 Aug; 36(8):2035-45. PubMed ID: 16841299
[TBL] [Abstract][Full Text] [Related]
3. Activated T cells induce rapid CD83 expression on B cells by engagement of CD40.
Kretschmer B; Kühl S; Fleischer B; Breloer M
Immunol Lett; 2011 May; 136(2):221-7. PubMed ID: 21277328
[TBL] [Abstract][Full Text] [Related]
4. CD83 regulates lymphocyte maturation, activation and homeostasis.
Breloer M; Fleischer B
Trends Immunol; 2008 Apr; 29(4):186-94. PubMed ID: 18329338
[TBL] [Abstract][Full Text] [Related]
5. CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells.
Kuwano Y; Prazma CM; Yazawa N; Watanabe R; Ishiura N; Kumanogoh A; Okochi H; Tamaki K; Fujimoto M; Tedder TF
Int Immunol; 2007 Aug; 19(8):977-92. PubMed ID: 17804692
[TBL] [Abstract][Full Text] [Related]
6. Engagement of CD83 on B cells modulates B cell function in vivo.
Kretschmer B; Lüthje K; Schneider S; Fleischer B; Breloer M
J Immunol; 2009 Mar; 182(5):2827-34. PubMed ID: 19234177
[TBL] [Abstract][Full Text] [Related]
7. Failed efficacy of soluble human CD83-Ig in allogeneic mixed lymphocyte reactions and experimental autoimmune encephalomyelitis: implications for a lack of therapeutic potential.
Pashine A; Göpfert U; Chen J; Hoffmann E; Dietrich PS; Peng SL
Immunol Lett; 2008 Jan; 115(1):9-15. PubMed ID: 18079004
[TBL] [Abstract][Full Text] [Related]
8. Direct contact of platelets and their released products exert different effects on human dendritic cell maturation.
Hamzeh-Cognasse H; Cognasse F; Palle S; Chavarin P; Olivier T; Delézay O; Pozzetto B; Garraud O
BMC Immunol; 2008 Sep; 9():54. PubMed ID: 18817542
[TBL] [Abstract][Full Text] [Related]
9. Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma.
Suzuki A; Masuda A; Nagata H; Kameoka S; Kikawada Y; Yamakawa M; Kasajima T
J Pathol; 2002 Jan; 196(1):37-43. PubMed ID: 11748640
[TBL] [Abstract][Full Text] [Related]
10. CD83 regulates splenic B cell maturation and peripheral B cell homeostasis.
Lüthje K; Kretschmer B; Fleischer B; Breloer M
Int Immunol; 2008 Aug; 20(8):949-60. PubMed ID: 18544574
[TBL] [Abstract][Full Text] [Related]
11. A limited course of soluble CD83 delays acute cellular rejection of MHC-mismatched mouse skin allografts.
Xu JF; Huang BJ; Yin H; Xiong P; Feng W; Xu Y; Fang M; Zheng F; Wang CY; Gong FL
Transpl Int; 2007 Mar; 20(3):266-76. PubMed ID: 17291220
[TBL] [Abstract][Full Text] [Related]
12. CD83: an update on functions and prospects of the maturation marker of dendritic cells.
Prechtel AT; Steinkasserer A
Arch Dermatol Res; 2007 May; 299(2):59-69. PubMed ID: 17334966
[TBL] [Abstract][Full Text] [Related]
13. CD83 on murine APC does not function as a costimulatory receptor for T cells.
Kretschmer B; Lüthje K; Ehrlich S; Osterloh A; Piedavent M; Fleischer B; Breloer M
Immunol Lett; 2008 Oct; 120(1-2):87-95. PubMed ID: 18675848
[TBL] [Abstract][Full Text] [Related]
14. Role of CD83 in the immunomodulation of dendritic cells.
Lechmann M; Zinser E; Golka A; Steinkasserer A
Int Arch Allergy Immunol; 2002 Oct; 129(2):113-8. PubMed ID: 12403928
[TBL] [Abstract][Full Text] [Related]
15. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
16. CD83 expression on dendritic cells and T cells: correlation with effective immune responses.
Aerts-Toegaert C; Heirman C; Tuyaerts S; Corthals J; Aerts JL; Bonehill A; Thielemans K; Breckpot K
Eur J Immunol; 2007 Mar; 37(3):686-95. PubMed ID: 17301951
[TBL] [Abstract][Full Text] [Related]
17. CD83: regulator of central T cell maturation and peripheral immune response.
Breloer M
Immunol Lett; 2008 Jan; 115(1):16-7. PubMed ID: 18022250
[No Abstract] [Full Text] [Related]
18. The soluble form of CD83 dramatically changes the cytoskeleton of dendritic cells.
Kotzor N; Lechmann M; Zinser E; Steinkasserer A
Immunobiology; 2004; 209(1-2):129-40. PubMed ID: 15481147
[TBL] [Abstract][Full Text] [Related]
19. The heat stable antigen (CD24) is not required for the generation of CD4+ effector and memory T cells by dendritic cells in vivo.
de Heusch M; Garzé V; Maliszewski C; Urbain J; Liu Y; Moser M
Immunol Lett; 2004 Jul; 94(3):229-37. PubMed ID: 15275971
[TBL] [Abstract][Full Text] [Related]
20. Published studies reporting the efficacy of soluble CD83 in vitro as well as in vivo.
Zinser E; Steinkasserer A
Immunol Lett; 2008 Jan; 115(1):18-9. PubMed ID: 18054088
[No Abstract] [Full Text] [Related]
[Next] [New Search]
